Company intelligence / Profile preview

Luna Labs

Charlottesville, Virginia, United Stateslunalabs.us ↗

Ownership: Private
Development stage: Preclinical

Overview

Luna Labs develops novel materials-based solutions spanning biotechnology, medical devices, diagnostics, and advanced materials. Their NanoVac carbon nanotube-based drug/vaccine delivery system is in early development. The company has commercialized bleeding control training simulators used globally by first responders. Other products include sprayable hydrogels for postoperative adhesion prevention and point-of-care diagnostic tools. Clinical results have not been published.

Therapeutic areas: OtherHematologyInfectious Diseases
Modalities: NanoparticleHydrogel-based drug delivery therapyDeviceSmall molecule
Industry: Biotech

Drug pipeline

1 asset

AeroVeil

Preclinical

Partnerships

Parimer Scientific (manufacturing scale-up of hydrogel product)

Beyond the preview

Go deeper on Luna Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luna Labs.